Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Qinghai Biotech Pharmaceutical Group Limited, an investment holding company, engages in the health care and dental business in the People's Republic of China and internationally. It produces and sells dental prosthetics, including crowns and bridges, removable full and partial dentures, implants, and full-cast restorations, as well as provides sport rehabilitation services comprising postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction, and other rehabilitation services; and health leisure services. The company is also involved in the investment holding of loan receivable; provision of medical consultation and other medical services; and trading and provision of medical technology development. In addition, it trades in dental prosthetics, implant instruments, and other dental products. The company was formerly known as Kaisa Health Group Holdings Limited and changed its name to Qinghai Biotech Pharmaceutical Group Limited in September 2026. Qinghai Biotech Pharmaceutical Group Limited was founded in 1971 and is headquartered in Central, Hong Kong.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers.